Number of the records: 1
The Peptidic GHS-R antagonist [D-Lys3]GHRP-6 markedly improves adiposity and related metabolic abnormalities in a mouse model of postmenopausal obesity
- 1.Maletínská, L., Matyšková, R., Maixnerová, J., Sýkora, D., Pýchová, M., Špolcová, A., Blechová, M., Drápalová, J., Lacinová, Z., Haluzík, M., Železná, B. The Peptidic GHS-R antagonist [D-Lys3]GHRP-6 markedly improves adiposity and related metabolic abnormalities in a mouse model of postmenopausal obesity. Molecular and Cellular Endocrinology. 2011, 343(1/2), 55-62. ISSN 0303-7207. E-ISSN 1872-8057. Available: doi: 10.1016/j.mce.2011.06.006
Number of the records: 1